Yazar "Alp, Mehmet Numan" seçeneğine göre listele

Listeleniyor 1 - 2 / 2
  • Küçük Resim Yok
    Öğe
    Evaluation of the Effect of Proptosis on Choroidal Thickness in Graves' Ophthalmopathy
    (Turkish Ophthalmological Soc, 2020) Yildirim, Gamze; Sahli, Esra; Alp, Mehmet Numan
    Objectives: To evaluate the effect of proptosis on choroidal thickness in patients with Graves' ophthalmopathy. Materials and Methods: Twenty-five eyes of 25 Graves' patients with proptosis, 25 eyes of 25 Graves' patients without proptosis, and 25 eyes of 25 healthy individuals were included in this prospective study. The subfoveal choroidal thickness and choroidal thicknesses at 6 points from the fovea at 500 mu m intervals were measured by Cirrus HD-OCT. All measurements were compared among the proptosis, non-proptosis, and control groups and the active, inactive, and control groups. Results: The mean subfoveal choroidal thickness in the proptosis group was 289.7 +/- 68.5 mu m, 322.5 +/- 55.8 mu m in the non-proptosis group, and 316.1 +/- 63.0 mu m in the control group. The mean nasal choroidal thickness was 260.5 +/- 63.5 mu m in the proptosis group, 293.9 +/- 57.9 mu m in the non-proptosis group, and 279.5 +/- 63.1 mu m in the control group. The mean temporal choroidal thickness was 261.8 +/- 60.9 mu m in the proptosis group, 289.0 +/- 51.8 mu m in the non-proptosis group, and 287.8 +/- 56.2 mu m in the control group. Mean choroidal thickness was 264.7 +/- 58.5 mu m in the proptosis group, 296.2 +/- 47.5 mu m in the non-proptosis group, and 288.3 +/- 55.1 mu m in the control group. There were no statistically significant differences among the groups with respect to choroidal thickness measurements (p>0.05). Conclusion: No significant difference in choroidal thickness was detected between Graves' patients with and without proptosis and the controls. There was no effect of clinical activation on choroidal thickness.
  • Küçük Resim Yok
    Öğe
    Vogt Koyanagi Harada syndrome in a 15-year-old girl, steroids side effects and recurrences
    (Turkish J Pediatrics, 2021) Yildirim, Gamze; Cavdarli, Cemal; Ozdemir, Emine Yildiz; Alp, Mehmet Numan
    Background. Vogt-Koyanagi-Harada Syndrome is rare in childhood and is usually seen between the 2nd and 5th decades. We present a 15-year-old girl with findings of incomplete Vogt-Koyanagi-Harada Syndrome. Case. In the first visit, anterior chamber inflammation, vitritis, serous retinal detachment and papillitis were observed in her both eyes. She also had neurological symptoms such as a headache. During the systemic treatment period, some of the side effects related to steroids emerged. Additionally, the symptoms and findings of the disease relapsed while the steroid dose was reduced. Conclusion. Early diagnosis and selection of an individualized appropriate treatment provided good clinical and visual results without any serious complications in our case.